… we discussed reading or sequencing genes and proteins to better understand Parkinson's -- from its causes to the way it shows itself in symptoms and progression. Defining what is different in DNA and RNA of people with Parkinson's can lead to ways to …

… might be new or even intimidating. But many are pleased to learn that there are many ways to participate in … and is safe. Still some studies are conducted from the comfort of your home. In this research roundup blog, we … be interviewed via video call and given instructions on how to use a smartwatch and a smartphone with a …

… A Phase II trial evaluating a novel therapy to treat Parkinson's disease dementia (PDD) is actively … thoughts, as well as memory loss and dementia. The new compound in testing, SYN120, may address cognitive function … of the trial. The baseline visit may take 6 to 9 hours; however, some sites allow participants to split the time …

… (MJFF) announces the acquisition of a library of research tools around the parkin protein from Imago Pharmaceuticals. … The Foundation believes these tools — cell lines, plasmids, compounds and more — will accelerate biological study and … development against this promising disease-modification target. Imago purchased the tools as part of a deal with health …

… area will gather for a family-friendly afternoon of jazz in support of Team Fox. Co-hosted by Bruce Lundvall , Blue Note … Bruce's continued passion for jazz is being channeled into a unique opportunity to raise awareness and support for a … Bruce Lundvall: Playing by Ear. All tickets include complimentary cocktails and tapas.  Liz Diemer Director Team …

… the build-up of alpha-synuclein inside nerve cells leads to formation of abnormal clumps and death of … can be used to monitor the effects of therapies that target the genetic mutations in PD. Lastly, we will further … Steps for Development: We will work with pharmaceutical companies and other stakeholders to develop a diagnostic kit …